Dyad Oxytocin Study (DOS)
| Status: | Completed |
|---|---|
| Conditions: | Schizophrenia, Neurology, Psychiatric, Autism |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 12/7/2018 |
| Start Date: | April 2011 |
| End Date: | October 2017 |
Effects of Oxytocin on Familial Interactions
The purpose of the investigators proposed study is twofold: 1) To investigate the role of the
affiliative neuropeptide oxytocin in unhealthy interactions in families of patients with
schizophrenia and families of patients with autism spectrum disorder, and 2) to investigate
whether manipulation of this oxytocinergic system positively influences these family
interactions.
affiliative neuropeptide oxytocin in unhealthy interactions in families of patients with
schizophrenia and families of patients with autism spectrum disorder, and 2) to investigate
whether manipulation of this oxytocinergic system positively influences these family
interactions.
Inclusion Criteria:
- Inclusion criteria for caregiver of patients with schizophrenia, patients with autism
spectrum disorder, and healthy controls:
- Age between 18 and 75 years old
- Must have at least 4 hours of contact with the patient per week and be considered a
"significant caregiver" by the patient
Inclusion criteria for patients with schizophrenia:
- Between the ages of 14 and 45.
- Patients must have a diagnosis of schizophrenia, schizophreniform disorder,
schizoaffective disorder or psychosis- Not Otherwise Specified (NOS).
- Patients must be clinically stable
- No or minor changes to medications in the past week
- Patients must have a primary caregiver
- Inclusion criteria for healthy control child:
- Between the ages of 14 and 45
- Healthy control must have a primary caregiver
- Inclusion criteria for patients with autism spectrum disorder
- Between the ages of 14 and 45
- Patient must have a primary caregiver
- Patients must have a diagnosis of an autism spectrum disorder (ASD) (autism or
Asperger's disorder), pervasive developmental disorder (PDD) or pervasive
developmental disorder - not otherwise specified (PDD-NOS).
Exclusion Criteria:
Exclusion criteria for all caregivers:
- Female caregivers that state that they are pregnant or have a positive urine pregnancy
test
- Caregivers who have significant nasal pathology, atrophic rhinitis, recurrent nose
bleeds, or history of cranial-surgical procedures (hypophysectomy)
- Caregivers with significant psychiatric, neurologic, or medical illness
- Exclusion criteria for healthy controls:
- Healthy controls with history of psychiatric or neurological illness
- Exclusion criteria for patients with an autism spectrum disorder:
- Patients with an Intelligence Quotient (IQ) lower than 75
- Exclusion criteria for patients with schizophrenia
- Patients with severe brain trauma
We found this trial at
1
site
San Francisco, California 94143
Principal Investigator: Joshua D Woolley, MD, PhD
Phone: 415-504-2263
Click here to add this to my saved trials
